English
简体中文
Total: £ 56.28
Published Date: 2025-11-12 | Pages: 125 | Tables: 118 | Medical Care
The global Life Sciences IT market is projected to grow from US$ 23800 million in 2024 to US$ 48920 million by 2031, at a CAGR of 11.0% (2025-2031), driven by critical product segments and diverse end‑use applications.
Life science IT plays a crucial role in life sciences by providing sophisticated tools and solutions to manage, analyze, and interpret complex biological data. Life science IT solutions are designed to streamline various processes within the life sciences domain, including research, drug discovery, clinical trials, and healthcare management. Life science IT software typically includes applications for data management, analysis, and visualization, facilitating the collection, storage, and interpretation of complex biological and clinical data. Life science IT solutions enable researchers to conduct experiments, analyze results, and make informed decisions in areas such as drug discovery, genomics, proteomics, and personalized medicine. Additionally, life science IT software often incorporates features for regulatory compliance, quality control, and collaboration, ensuring that organizations adhere to industry standards and best practices while fostering teamwork and knowledge sharing among multidisciplinary teams.
The life sciences IT market size in expected to grow significantly, owing to high demand for advance analytical tool to analyze and manage large data generated in the healthcare sector, rise in adoption of the life science IT technology in the drug discovery and development, and growing trend towards digitalization of the healthcare system. According to life sciences IT market forecast, rise in demand for advanced analytical tools is expected to act as a significant driver for the growth of the life sciences IT market. The exponential increase in the volume of data generated within healthcare, fueled by electronic health records, genomic information, and real-time patient monitoring systems, has resulted in increase in demand for sophisticated analytical solutions for efficient analysis and management. For instance, according to a 2023 report by the National Library of Medicine, over 80% of digital data in healthcare is available as unstructured data, requiring new forms of data processing and standardizing that prove challenging to health researchers.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Life Sciences IT market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Thermo Fisher Scientific Inc
Oracle Corporation
Revvity, Inc
Clario
Illumina, Inc
Qiagen NV
Agilent Technologies, Inc
IBM Corporation
Genedata AG
DNAnexus, Inc
Segment by Type
Software
Services
Segment by Application
Pharmaceutical and Biotechnology Companies
Contract Research and Development Organizations
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Life Sciences IT study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Life Sciences IT: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Life Sciences IT Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Software
1.2.3 Services
1.3 Market Segmentation by Application
1.3.1 Global Life Sciences IT Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Contract Research and Development Organizations
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Life Sciences IT Revenue Estimates and Forecasts 2020-2031
2.2 Global Life Sciences IT Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Life Sciences IT Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Life Sciences IT Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Software Market Size by Players
3.3.2 Services Market Size by Players
3.4 Global Life Sciences IT Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Life Sciences IT Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Life Sciences IT Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Life Sciences IT Market Size by Type (2020-2031)
6.4 North America Life Sciences IT Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Life Sciences IT Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Life Sciences IT Market Size by Type (2020-2031)
7.4 Europe Life Sciences IT Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Life Sciences IT Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Life Sciences IT Market Size by Type (2020-2031)
8.4 Asia-Pacific Life Sciences IT Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Life Sciences IT Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Life Sciences IT Market Size by Type (2020-2031)
9.4 Central and South America Life Sciences IT Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Life Sciences IT Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Life Sciences IT Market Size by Type (2020-2031)
10.4 Middle East and Africa Life Sciences IT Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Life Sciences IT Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Thermo Fisher Scientific Inc
11.1.1 Thermo Fisher Scientific Inc Corporation Information
11.1.2 Thermo Fisher Scientific Inc Business Overview
11.1.3 Thermo Fisher Scientific Inc Life Sciences IT Product Features and Attributes
11.1.4 Thermo Fisher Scientific Inc Life Sciences IT Revenue and Gross Margin (2020-2025)
11.1.5 Thermo Fisher Scientific Inc Life Sciences IT Revenue by Product in 2024
11.1.6 Thermo Fisher Scientific Inc Life Sciences IT Revenue by Application in 2024
11.1.7 Thermo Fisher Scientific Inc Life Sciences IT Revenue by Geographic Area in 2024
11.1.8 Thermo Fisher Scientific Inc Life Sciences IT SWOT Analysis
11.1.9 Thermo Fisher Scientific Inc Recent Developments
11.2 Oracle Corporation
11.2.1 Oracle Corporation Corporation Information
11.2.2 Oracle Corporation Business Overview
11.2.3 Oracle Corporation Life Sciences IT Product Features and Attributes
11.2.4 Oracle Corporation Life Sciences IT Revenue and Gross Margin (2020-2025)
11.2.5 Oracle Corporation Life Sciences IT Revenue by Product in 2024
11.2.6 Oracle Corporation Life Sciences IT Revenue by Application in 2024
11.2.7 Oracle Corporation Life Sciences IT Revenue by Geographic Area in 2024
11.2.8 Oracle Corporation Life Sciences IT SWOT Analysis
11.2.9 Oracle Corporation Recent Developments
11.3 Revvity, Inc
11.3.1 Revvity, Inc Corporation Information
11.3.2 Revvity, Inc Business Overview
11.3.3 Revvity, Inc Life Sciences IT Product Features and Attributes
11.3.4 Revvity, Inc Life Sciences IT Revenue and Gross Margin (2020-2025)
11.3.5 Revvity, Inc Life Sciences IT Revenue by Product in 2024
11.3.6 Revvity, Inc Life Sciences IT Revenue by Application in 2024
11.3.7 Revvity, Inc Life Sciences IT Revenue by Geographic Area in 2024
11.3.8 Revvity, Inc Life Sciences IT SWOT Analysis
11.3.9 Revvity, Inc Recent Developments
11.4 Clario
11.4.1 Clario Corporation Information
11.4.2 Clario Business Overview
11.4.3 Clario Life Sciences IT Product Features and Attributes
11.4.4 Clario Life Sciences IT Revenue and Gross Margin (2020-2025)
11.4.5 Clario Life Sciences IT Revenue by Product in 2024
11.4.6 Clario Life Sciences IT Revenue by Application in 2024
11.4.7 Clario Life Sciences IT Revenue by Geographic Area in 2024
11.4.8 Clario Life Sciences IT SWOT Analysis
11.4.9 Clario Recent Developments
11.5 Illumina, Inc
11.5.1 Illumina, Inc Corporation Information
11.5.2 Illumina, Inc Business Overview
11.5.3 Illumina, Inc Life Sciences IT Product Features and Attributes
11.5.4 Illumina, Inc Life Sciences IT Revenue and Gross Margin (2020-2025)
11.5.5 Illumina, Inc Life Sciences IT Revenue by Product in 2024
11.5.6 Illumina, Inc Life Sciences IT Revenue by Application in 2024
11.5.7 Illumina, Inc Life Sciences IT Revenue by Geographic Area in 2024
11.5.8 Illumina, Inc Life Sciences IT SWOT Analysis
11.5.9 Illumina, Inc Recent Developments
11.6 Qiagen NV
11.6.1 Qiagen NV Corporation Information
11.6.2 Qiagen NV Business Overview
11.6.3 Qiagen NV Life Sciences IT Product Features and Attributes
11.6.4 Qiagen NV Life Sciences IT Revenue and Gross Margin (2020-2025)
11.6.5 Qiagen NV Recent Developments
11.7 Agilent Technologies, Inc
11.7.1 Agilent Technologies, Inc Corporation Information
11.7.2 Agilent Technologies, Inc Business Overview
11.7.3 Agilent Technologies, Inc Life Sciences IT Product Features and Attributes
11.7.4 Agilent Technologies, Inc Life Sciences IT Revenue and Gross Margin (2020-2025)
11.7.5 Agilent Technologies, Inc Recent Developments
11.8 IBM Corporation
11.8.1 IBM Corporation Corporation Information
11.8.2 IBM Corporation Business Overview
11.8.3 IBM Corporation Life Sciences IT Product Features and Attributes
11.8.4 IBM Corporation Life Sciences IT Revenue and Gross Margin (2020-2025)
11.8.5 IBM Corporation Recent Developments
11.9 Genedata AG
11.9.1 Genedata AG Corporation Information
11.9.2 Genedata AG Business Overview
11.9.3 Genedata AG Life Sciences IT Product Features and Attributes
11.9.4 Genedata AG Life Sciences IT Revenue and Gross Margin (2020-2025)
11.9.5 Genedata AG Recent Developments
11.10 DNAnexus, Inc
11.10.1 DNAnexus, Inc Corporation Information
11.10.2 DNAnexus, Inc Business Overview
11.10.3 DNAnexus, Inc Life Sciences IT Product Features and Attributes
11.10.4 DNAnexus, Inc Life Sciences IT Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Life Sciences ITIndustry Chain Analysis
12.1 Life Sciences IT Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Life Sciences IT Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Life Sciences IT Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Life Sciences IT Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Life Sciences IT Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Life Sciences IT Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Life Sciences IT Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Life Sciences IT Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Life Sciences IT Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Life Sciences IT Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Life Sciences IT by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Life Sciences IT as of 2024)
Table 11. Global Life Sciences IT Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Life Sciences IT Companies Headquarters
Table 13. Global Life Sciences IT Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Life Sciences IT Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Life Sciences IT Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Life Sciences IT Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Life Sciences IT Revenue by Application (2026-2031) & (US$ Million)
Table 21. Life Sciences IT High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Life Sciences IT Growth Accelerators and Market Barriers
Table 25. North America Life Sciences IT Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Life Sciences IT Growth Accelerators and Market Barriers
Table 27. Europe Life Sciences IT Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Life Sciences IT Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Life Sciences IT Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Life Sciences IT Investment Opportunities and Key Challenges
Table 31. Central and South America Life Sciences IT Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Life Sciences IT Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Life Sciences IT Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Thermo Fisher Scientific Inc Corporation Information
Table 35. Thermo Fisher Scientific Inc Description and Major Businesses
Table 36. Thermo Fisher Scientific Inc Product Features and Attributes
Table 37. Thermo Fisher Scientific Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Thermo Fisher Scientific Inc Revenue Proportion by Product in 2024
Table 39. Thermo Fisher Scientific Inc Revenue Proportion by Application in 2024
Table 40. Thermo Fisher Scientific Inc Revenue Proportion by Geographic Area in 2024
Table 41. Thermo Fisher Scientific Inc Life Sciences IT SWOT Analysis
Table 42. Thermo Fisher Scientific Inc Recent Developments
Table 43. Oracle Corporation Corporation Information
Table 44. Oracle Corporation Description and Major Businesses
Table 45. Oracle Corporation Product Features and Attributes
Table 46. Oracle Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Oracle Corporation Revenue Proportion by Product in 2024
Table 48. Oracle Corporation Revenue Proportion by Application in 2024
Table 49. Oracle Corporation Revenue Proportion by Geographic Area in 2024
Table 50. Oracle Corporation Life Sciences IT SWOT Analysis
Table 51. Oracle Corporation Recent Developments
Table 52. Revvity, Inc Corporation Information
Table 53. Revvity, Inc Description and Major Businesses
Table 54. Revvity, Inc Product Features and Attributes
Table 55. Revvity, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. Revvity, Inc Revenue Proportion by Product in 2024
Table 57. Revvity, Inc Revenue Proportion by Application in 2024
Table 58. Revvity, Inc Revenue Proportion by Geographic Area in 2024
Table 59. Revvity, Inc Life Sciences IT SWOT Analysis
Table 60. Revvity, Inc Recent Developments
Table 61. Clario Corporation Information
Table 62. Clario Description and Major Businesses
Table 63. Clario Product Features and Attributes
Table 64. Clario Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. Clario Revenue Proportion by Product in 2024
Table 66. Clario Revenue Proportion by Application in 2024
Table 67. Clario Revenue Proportion by Geographic Area in 2024
Table 68. Clario Life Sciences IT SWOT Analysis
Table 69. Clario Recent Developments
Table 70. Illumina, Inc Corporation Information
Table 71. Illumina, Inc Description and Major Businesses
Table 72. Illumina, Inc Product Features and Attributes
Table 73. Illumina, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. Illumina, Inc Revenue Proportion by Product in 2024
Table 75. Illumina, Inc Revenue Proportion by Application in 2024
Table 76. Illumina, Inc Revenue Proportion by Geographic Area in 2024
Table 77. Illumina, Inc Life Sciences IT SWOT Analysis
Table 78. Illumina, Inc Recent Developments
Table 79. Qiagen NV Corporation Information
Table 80. Qiagen NV Description and Major Businesses
Table 81. Qiagen NV Product Features and Attributes
Table 82. Qiagen NV Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Qiagen NV Recent Developments
Table 84. Agilent Technologies, Inc Corporation Information
Table 85. Agilent Technologies, Inc Description and Major Businesses
Table 86. Agilent Technologies, Inc Product Features and Attributes
Table 87. Agilent Technologies, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Agilent Technologies, Inc Recent Developments
Table 89. IBM Corporation Corporation Information
Table 90. IBM Corporation Description and Major Businesses
Table 91. IBM Corporation Product Features and Attributes
Table 92. IBM Corporation Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. IBM Corporation Recent Developments
Table 94. Genedata AG Corporation Information
Table 95. Genedata AG Description and Major Businesses
Table 96. Genedata AG Product Features and Attributes
Table 97. Genedata AG Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Genedata AG Recent Developments
Table 99. DNAnexus, Inc Corporation Information
Table 100. DNAnexus, Inc Description and Major Businesses
Table 101. DNAnexus, Inc Product Features and Attributes
Table 102. DNAnexus, Inc Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. DNAnexus, Inc Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Life Sciences IT Product Picture
Figure 2. Global Life Sciences IT Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Software Product Picture
Figure 4. Services Product Picture
Figure 5. Global Life Sciences IT Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 6. Pharmaceutical and Biotechnology Companies
Figure 7. Contract Research and Development Organizations
Figure 8. Others
Figure 9. Life Sciences IT Report Years Considered
Figure 10. Global Life Sciences IT Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 11. Global Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 12. Global Life Sciences IT Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 13. Global Life Sciences IT Revenue Market Share by Region (2020-2031)
Figure 14. Global Life Sciences IT Revenue Market Share Ranking (2024)
Figure 15. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 16. Software Revenue Market Share by Player in 2024
Figure 17. Services Revenue Market Share by Player in 2024
Figure 18. Global Life Sciences IT Revenue Market Share by Type (2020-2031)
Figure 19. Global Life Sciences IT Revenue Market Share by Application (2020-2031)
Figure 20. North America Life Sciences IT Revenue YoY (2020-2031) & (US$ Million)
Figure 21. North America Top 5 Players Life Sciences IT Revenue (US$ Million) in 2024
Figure 22. North America Life Sciences IT Revenue (US$ Million) by Type (2020 - 2031)
Figure 23. North America Life Sciences IT Revenue (US$ Million) by Application (2020-2031)
Figure 24. US Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 25. Canada Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 26. Mexico Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 27. Europe Life Sciences IT Revenue YoY (2020-2031) & (US$ Million)
Figure 28. Europe Top 5 Players Life Sciences IT Revenue (US$ Million) in 2024
Figure 29. Europe Life Sciences IT Revenue (US$ Million) by Type (2020-2031)
Figure 30. Europe Life Sciences IT Revenue (US$ Million) by Application (2020-2031)
Figure 31. Germany Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 32. France Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 33. U.K. Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 34. Italy Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 35. Russia Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Life Sciences IT Revenue YoY (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Top 8 Players Life Sciences IT Revenue (US$ Million) in 2024
Figure 38. Asia-Pacific Life Sciences IT Revenue (US$ Million) by Type (2020-2031)
Figure 39. Asia-Pacific Life Sciences IT Revenue (US$ Million) by Application (2020-2031)
Figure 40. Indonesia Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 41. Japan Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 42. South Korea Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 43. Australia Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 44. India Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 45. Indonesia Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 46. Vietnam Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 47. Malaysia Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 48. Philippines Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 49. Singapore Life Sciences IT Revenue (2020-2031) & (US$ Million)
Figure 50. Central and South America Life Sciences IT Revenue YoY (2020-2031) & (US$ Million)
Figure 51. Central and South America Top 5 Players Life Sciences IT Revenue (US$ Million) in 2024
Figure 52. Central and South America Life Sciences IT Revenue (US$ Million) by Type (2020-2031)
Figure 53. Central and South America Life Sciences IT Revenue (US$ Million) by Application (2020-2031)
Figure 54. Brazil Life Sciences IT Revenue (2020-2025) & (US$ Million)
Figure 55. Argentina Life Sciences IT Revenue (2020-2025) & (US$ Million)
Figure 56. Middle East and Africa Life Sciences IT Revenue YoY (2020-2031) & (US$ Million)
Figure 57. Middle East and Africa Top 5 Players Life Sciences IT Revenue (US$ Million) in 2024
Figure 58. South America Life Sciences IT Revenue (US$ Million) by Type (2020-2031)
Figure 59. Middle East and Africa Life Sciences IT Revenue (US$ Million) by Application (2020-2031)
Figure 60. GCC Countries Life Sciences IT Revenue (2020-2025) & (US$ Million)
Figure 61. Israel Life Sciences IT Revenue (2020-2025) & (US$ Million)
Figure 62. Egypt Life Sciences IT Revenue (2020-2025) & (US$ Million)
Figure 63. South Africa Life Sciences IT Revenue (2020-2025) & (US$ Million)
Figure 64. Life Sciences IT Industry Chain Mapping
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
